^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Uterine Corpus Leiomyosarcoma |
| Drug: | Votrient (pazopanib) (Multi-tyrosine kinase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
...other single agent options...can also be considered for advanced or metastatic disease, including dacarbazine...pazopanib...
